Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
Vaccines and functional neurological disorder: A complex story, say experts. Vaccines and functional neurological disorder: A complex story, say experts. Key Takeaways • Functional neurological disorder can present with a range of potentially
Mariya and Rado met in their native Bulgaria, after a career opportunity brought Rado to Massachusetts the two were married. This story follows their fertility story and experience with the Massachusetts General Hospital Fertility Center.
A Message from Peter L. Slavin, MD to Colleagues. A Message from Peter L. Slavin, MD to Colleagues. Dear Colleagues, The day in January 2003 when I became president of Massachusetts General Hospital was one of the most humbling and meaningful days of
Peter L. Slavin, MD, Announces Intentions to Step Down as MGH President
A Message from Jonathan Kraft, Chair of the MGH Board of Trustees. A Message from Jonathan Kraft, Chair of the MGH Board of Trustees. Dear MGH Community, From the day I first met Peter Slavin in September 1988–the day he walked in late to the first
I am writing today to share that one of our most accomplished and inspirational leaders—Peter L. Slavin, MD, President, Massachusetts General Hospital (Mass General)—has informed me that he intends to step down after 18 years in this role.
The results of your patient’s blood test for celiac disease can help you figure out the best next steps for them. Learn what to expect after your patient’s blood test for celiac disease.
View the full collection of provider resources from the Center for Celiac Research and Treatment at MGHfC
In recognition of National Donate Life Month, the living donor team at Massachusetts General Hospital collected reflections from a few of our previous donors about their experience and their advice for anyone who is interested to become a living donor.
Scientists uncover mutations that make cancer resistant to therapies targeting KRAS. Scientists uncover mutations that make cancer resistant to therapies targeting KRAS. Key Takeaways • Cancer drugs that inhibit the protein expressed by a mutated
Members of the media can reach the News and Public Affairs staff by phone.